TY - JOUR
T1 - Influence of clinical parameters on the results of 13C-octanoic acid breath tests
T2 - Examination of different mathematical models in a large patient cohort
AU - Keller, J.
AU - Andresen, V.
AU - Wolter, J.
AU - Layer, P.
AU - Camilleri, M.
PY - 2009/10
Y1 - 2009/10
N2 - It is assumed, although not proven, that 13CO 2-excretion following ingestion of 13C-octanoic acid (13C-OA) does not only depend on gastric emptying (GE) but also on absorption and metabolism of 13C-OA and endogenous CO 2-production. Our aims were (i) to test the effects of patient characteristics and of diseases that may impair 13C-OA-metabolism on GE parameters. (ii) To compare different GE endpoints. Therefore, we investigated effects of age, gender, BMI and diseases with potential impact on 13C-OA-metabolism (including pancreatic, liver and lung disease, diabetes, IBD) on cumulative 4h-13CO2-excretion (4h-CUM) and T calculated by non-linear regression model (NL, determined by shape of breath test curve) and generalized linear regression model (GLR, reflects absolute 13CO2-excretion) in 1279 patients and 19 healthy controls who underwent a standardized 13C-OA-breath test. Digestive and metabolic disturbances hardly influenced 4h-CUM or T calculated by NL or GLR models. In the multivariate linear regression models, 4h-CUM was significantly predicted by diabetes adjusted for age, gender and IBD but influence of these parameters was small (R2=10.028, P < 0.0001). T NL and 4h-CUM were weakly correlated, even after exclusion of tests with unrealistically high estimates for TNL (n = 1095, R 2=10.029, P < 0.0001). Conversely, 4h-CUM was closely associated with TGLR (exponential correlation, R2= 10.774, P < 0.00001, n = 1279). We conclude that influences of digestive and metabolic disturbances on 13CO2-excretion following 13C-OA-application are generally low. Thus, our findings resolve an important criticism of methods using absolute 13CO 2-excretion for evaluation of 13C-OA-breath tests and suggest that such models may correctly identify T in a mixed patient population.
AB - It is assumed, although not proven, that 13CO 2-excretion following ingestion of 13C-octanoic acid (13C-OA) does not only depend on gastric emptying (GE) but also on absorption and metabolism of 13C-OA and endogenous CO 2-production. Our aims were (i) to test the effects of patient characteristics and of diseases that may impair 13C-OA-metabolism on GE parameters. (ii) To compare different GE endpoints. Therefore, we investigated effects of age, gender, BMI and diseases with potential impact on 13C-OA-metabolism (including pancreatic, liver and lung disease, diabetes, IBD) on cumulative 4h-13CO2-excretion (4h-CUM) and T calculated by non-linear regression model (NL, determined by shape of breath test curve) and generalized linear regression model (GLR, reflects absolute 13CO2-excretion) in 1279 patients and 19 healthy controls who underwent a standardized 13C-OA-breath test. Digestive and metabolic disturbances hardly influenced 4h-CUM or T calculated by NL or GLR models. In the multivariate linear regression models, 4h-CUM was significantly predicted by diabetes adjusted for age, gender and IBD but influence of these parameters was small (R2=10.028, P < 0.0001). T NL and 4h-CUM were weakly correlated, even after exclusion of tests with unrealistically high estimates for TNL (n = 1095, R 2=10.029, P < 0.0001). Conversely, 4h-CUM was closely associated with TGLR (exponential correlation, R2= 10.774, P < 0.00001, n = 1279). We conclude that influences of digestive and metabolic disturbances on 13CO2-excretion following 13C-OA-application are generally low. Thus, our findings resolve an important criticism of methods using absolute 13CO 2-excretion for evaluation of 13C-OA-breath tests and suggest that such models may correctly identify T in a mixed patient population.
KW - Absorption
KW - CO-excretion
KW - Gastric emptying test
KW - Gastroparesis
KW - Motility
KW - Scintigraphy
UR - http://www.scopus.com/inward/record.url?scp=70049085357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70049085357&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2982.2009.01340.x
DO - 10.1111/j.1365-2982.2009.01340.x
M3 - Article
C2 - 19549136
AN - SCOPUS:70049085357
SN - 1350-1925
VL - 21
SP - 1039-1046+e83
JO - Neurogastroenterology and Motility
JF - Neurogastroenterology and Motility
IS - 10
ER -